PUBLISHER: The Business Research Company | PRODUCT CODE: 1712727
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712727
Negative-pressure wound therapy (NPWT) is a therapeutic approach utilizing vacuum dressing to facilitate the healing process in acute or chronic wounds, as well as to enhance the healing of second and third-degree burns.
The primary product types within negative-pressure wound therapy include conventional NPWT devices and single-use NPWT devices. Conventional NPWT devices comprise a filler, often foam or gauze, covering the wound, a permeable membrane, and tubing connecting the space beneath the membrane to a suction mechanism. These components work together to create negative pressure, aiding in wound healing and management.
The negative pressure wound therapy (NPWT) research report is one of a series of new reports from The Business Research Company that provides negative pressure wound therapy (NPWT) statistics, including negative pressure wound therapy (NPWT) industry global market size, regional shares, competitors with negative pressure wound therapy (NPWT) shares, detailed negative pressure wound therapy (NPWT) segments, market trends and opportunities, and any further data you may need to thrive in the negative pressure wound therapy (NPWT) industry. This negative pressure wound therapy (NPWT) research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The negative pressure wound therapy market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to an aging population, hospital-acquired infections, a rise in surgical procedures, healthcare infrastructure development, and reimbursement policies.
The negative pressure wound therapy market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to the prevalence of lifestyle-related diseases, home-based healthcare, global health crisis preparedness, patient preference for non-invasive treatments, value-based healthcare models, increasing incidence of chronic wounds. Major trends in the forecast period include technological innovations, telemedicine integration, personalized wound care, collaborations and partnerships, regulatory compliance, and standardization.
The increasing prevalence of diabetes is anticipated to drive the growth of the negative pressure wound therapy market. Diabetic foot ulceration (DFU) represents the most common application of negative pressure wound therapy. Wounds in diabetic individuals are often difficult to heal due to poor circulation associated with uncontrolled diabetes, which leads to reduced oxygen flow to the wound and slower healing of the surrounding tissues. In this context, negative pressure wound therapy provides better graft acceptance compared to conventional dressings for diabetic patients. For example, in July 2023, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that 540 million people aged 20 to 79 were living with diabetes in 2022, with projections estimating that this number will rise to 643 million by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes is a key factor driving the demand for negative pressure wound therapy.
The increasing frequency of surgical procedures is expected to propel the negative pressure wound therapy (NPWT) market's growth. NPWT has proven efficacy in managing surgical wounds, reducing complications, accelerating healing, and enhancing patient quality of life. Surgeons and healthcare providers favor NPWT for wound care, supported by favorable reimbursement policies. For instance, according to the Organization for Economic Co-operation and Development, the Czech Republic witnessed an 8.4% surge in cataract surgical procedures, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. This surge in surgical procedures acts as a significant driver for the growth of the negative pressure wound therapy market.
The surge in technological advancements emerges as a prominent trend shaping the negative pressure wound therapy market. Key companies operating in this sector prioritize technological innovations in NPWT. For instance, in August 2022, 3M introduced the 3M Veraflo Cleanse Choice Complete Dressing Kit for negative pressure wound therapy along with a software upgrade for the 3M V.A.C. Ulta Therapy Unit. These novel offerings aim to streamline care delivery processes for clinicians and improve patient experiences by simplifying dressing changes, making them faster and less painful. The software upgrade automates therapy initiation and incorporates helpful features, while the new dressing kit includes a gentler drape for enhanced patient comfort. These innovations intend to enhance the efficiency and effectiveness of Veraflo Therapy in wound care.
Major players in the negative pressure wound therapy market are innovating by developing new portable and disposable NPWT devices to reinforce their market position. These devices, compact and single-use, apply controlled suction to wounds, aiding in healing by removing excess fluids and promoting optimal conditions for tissue recovery. Their mobility and elimination of complex traditional systems offer convenience. For instance, Advanced Oxygen Therapy Inc. launched the NEXA Negative Pressure Wound Therapy (NPWT) system in June 2023. This portable, silent, and cost-effective system combines the simplicity of disposable NPWT with the performance features of traditional durable NPWT technology. The NEXA NPWT system aims to enhance wound care performance at a lower cost, combining higher pressure oxygen delivery with non-contact cyclical compression and humidity for chronic wound care and healing.
In April 2022, Sanara MedTech Inc., a US-based healthcare company, merged with Precision Healing Inc. for an undisclosed amount. This merger strengthens Sanara's product offerings and reinforces its position in the advanced wound care sector, aligning with its mission to deliver innovative solutions that enhance patient care. Precision Healing Inc. is also a US-based medical equipment manufacturer that specializes in developing advanced diagnostic technologies for wound care and offers negative pressure wound therapy (NPWT).
Major companies operating in the negative pressure wound therapy market include Devon International Group, ConvaTec Group plc., DeRoyal Industries Inc., Smith & Nephew plc, Acelity L.P. Inc., Molnlycke Health Care AB, ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health Inc., Talley Group Limited, Medela AG, Lohmann & Rauscher GmbH & Co. KG, Triage Meditech Pvt. Ltd., Carilex Medical GmbH, Shandong Weigao Xinsheng Medical Devices Co. Lt, Genadyne Biotechnologies Inc., B. Braun Melsungen AG, Cork Medical LLC, BSN medical GmbH, Investor AB, Olle Larsson Holding AG, PAUL HARTMANN Asia-Pacific Ltd., KCI Licensing Inc., Arjo USA Inc., 3M Company, MPM Medical Inc., Prospera Technologies Inc., Innovative Therapies Inc., Laboratoires URGO, 4L Health Co. Ltd, Pensar Medical LLC, Virchow Biotech Pvt. Ltd., Arobella Medical LLC, Spincare Inc., Ursapharm Arzneimittel GmbH
North America was the largest region in the negative pressure wound therapy market in 2024. Asia-Pacific is the fastest growing region in the negative pressure wound therapy market share.The regions covered in the negative pressure wound therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, Africa.
The countries covered in the negative pressure wound therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The negative-pressure wound therapy (NPWT) market consists of sales of conventional NPWT devices, disposable NPWT devices, and NPWT accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Negative Pressure Wound Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on negative pressure wound therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for negative pressure wound therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The negative pressure wound therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.